
|Articles|March 31, 2022
OM1 Launches New Mental Health and Neuroscience Real-World Data Network
Advertisement
OM1 announced the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric disorders and diseases of the central nervous system (CNS) with an initial focus on major depression, schizophrenia, bipolar disorder, and multiple sclerosis (MS) with other condition areas to follow.
Read more about the new network
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility
2
Achieving Clinical Trial Success with Three Key Elements of eCOA User Acceptance Testing
3
2026 DIA Global Annual Meeting: How Structured Protocols Enable Automated Amendments and Real-Time FDA Oversight
4
2026 DIA Global Annual Meeting: Stacy Hurt of Parexel on Federated AI, the Patient Voice, and Accountability for Patient Needs
5




